Intravenous phenytoin: clinical and pharmacokinetic aspects. 1978

R E Cranford, and I E Leppik, and B Patrick, and C B Anderson, and B Kostick

Phenytoin was administered intravenously in large doses (mean = 16.6 mg per kilogram) for prevention and treatment of seizures on 159 occasions to 139 patients aged 17 to 94 years (mean = 52 years) and weighing 37 to 113 kg (mean = 65 kg). Hypotension was more frequent among older patients. No deaths were attributable to phenytoin. Volumes of distribution were relatively constant (mean = 0.78 +/- 0.11 liters per kilogram), but half-lives varied considerably and were prolonged (mean = 51 +/- 32 hours) because of the large doses administered. A dose of 18 mg per kilogram was effective in maintaining phenytoin serum levels above 10 microgram per milliliter for 24 hours.

UI MeSH Term Description Entries
D007022 Hypotension Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients. Blood Pressure, Low,Hypotension, Vascular,Low Blood Pressure,Vascular Hypotension
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R E Cranford, and I E Leppik, and B Patrick, and C B Anderson, and B Kostick
November 1981, Revista medica de Chile,
R E Cranford, and I E Leppik, and B Patrick, and C B Anderson, and B Kostick
June 1999, Drug and alcohol dependence,
R E Cranford, and I E Leppik, and B Patrick, and C B Anderson, and B Kostick
July 1989, Clinical pharmacology and therapeutics,
R E Cranford, and I E Leppik, and B Patrick, and C B Anderson, and B Kostick
February 1973, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
R E Cranford, and I E Leppik, and B Patrick, and C B Anderson, and B Kostick
January 1979, Clinical pharmacokinetics,
R E Cranford, and I E Leppik, and B Patrick, and C B Anderson, and B Kostick
June 1971, Anesthesiology,
R E Cranford, and I E Leppik, and B Patrick, and C B Anderson, and B Kostick
January 1977, The New England journal of medicine,
R E Cranford, and I E Leppik, and B Patrick, and C B Anderson, and B Kostick
November 1976, The New England journal of medicine,
R E Cranford, and I E Leppik, and B Patrick, and C B Anderson, and B Kostick
January 1983, Clinical pharmacy,
R E Cranford, and I E Leppik, and B Patrick, and C B Anderson, and B Kostick
December 2015, Seizure,
Copied contents to your clipboard!